Effect of traditional Chinese medicine Shu-Mai-Tang on attenuating TNFα-induced myocardial fibrosis in myocardial ischemia rats

Journal of Ethnopharmacology

Volumn 118, Issue 1, 2008, Pages 133-139

  Yin, Hui Qiu ^a   Wang, Bo ^a   Zhang, Ji Dong ^a   Lin, Hai Qing ^b   Qiao, Yun ^a   Wang, Rong ^a   Liu, Fen Ye ^a  

^a SHANDONG UNIVERSITY   (China)

^b SHANDONG UNIVERSITY OF TRADITIONAL CHINESE MEDICINE   (China)

Author keywords

Left ventricular remodeling; Myocardial fibrosis; Myocardial ischemia; p 38 mitogen activated protein kinase; Traditional Chinese medicine; Tumor necrosis factor alpha

Indexed keywords

ASTRAGALUS MONGHOLICUS EXTRACT; EUPOLYPHAGA SINENSIS EXTRACT; HIRUDO NIPPONICA EXTRACT; MITOGEN ACTIVATED PROTEIN KINASE P38; MOSCHUS BEREZOVSKII EXTRACT; PANAXPSEUDO GINSENG EXTRACT; PLANT EXTRACT; PLANT MEDICINAL PRODUCT; SALVIA MILTIORRHIZA EXTRACT; SHU MAI TANG; TISSUE INHIBITOR OF METALLOPROTEINASE 1; TRICHOSANTHES KIRILOWII EXTRACT; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CHINESE MEDICINE; CONCENTRATION RESPONSE; CONTROLLED STUDY; CORONARY ARTERY LIGATION; DOSE RESPONSE; DRUG MEGADOSE; ECHOCARDIOGRAPHY; ENZYME INHIBITION; ENZYME PHOSPHORYLATION; HEART FUNCTION; HEART LEFT VENTRICLE; HEART MUSCLE FIBROSIS; HEART MUSCLE ISCHEMIA; HISTOPATHOLOGY; INFLAMMATION; LEFT ANTERIOR DESCENDING CORONARY ARTERY; LOW DRUG DOSE; MALE; NONHUMAN; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; RADIOIMMUNOASSAY; RANDOMIZATION; RAT; SHAM PROCEDURE; SIGNAL TRANSDUCTION; TREATMENT DURATION; WESTERN BLOTTING;

ADMINISTRATION, ORAL; ANIMALS; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUGS, CHINESE HERBAL; FIBROSIS; MALE; MEDICINE, CHINESE TRADITIONAL; MYOCARDIAL ISCHEMIA; MYOCARDIUM; P38 MITOGEN-ACTIVATED PROTEIN KINASES; PHOSPHORYLATION; RANDOM ALLOCATION; RATS; RATS, WISTAR; TISSUE INHIBITOR OF METALLOPROTEINASE-1; TUMOR NECROSIS FACTOR-ALPHA; VENTRICULAR REMODELING;

RATTUS;

EID: 44149094010     PISSN: 03788741     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jep.2008.03.022     Document Type: Article

References (29)

1. Aggarwal B.B. Signalling pathways of the TNF superfamily: a double-edged sword. Nature Reviews Immunology 3 (2003) 745-756
2. An H.J., Jeong H.J., Kim H.M., and Hong S.H. Glechoma hederacea inhibits inflammatory mediator release in IFN-gamma and LPS-stimulated mouse peritoneal macrophages. Journal of Ethnopharmacology 106 (2006) 418-424
3. Behr T.M., Nerurkar S.S., Nelson A.H., Coatney R.W., Woods T.N., Sulpizio A., Chandra S., Brooks D.P., Kumar S., Lee J.C., Ohlstein E.H., Angermann C.E., Adams J.L., Sisko J., Sackner-Bernstein J.D., and Willette R.N. Hypertensive end-organ damage and premature mortality are p38 mitogen-activated protein kinase-dependent in a rat model of cardiac hypertrophy and dysfunction. Circulation 104 (2001) 1292-1298
4. Bondeson J. The mechanisms of action of disease-modifying antirheumatic drugs: a review with emphasis on macrophage signal transduction and the induction of proinflammatory cytokines. General Pharmacology 29 (1997) 127-150
5. Bryant D., Becker L., Richardson J., Shelton J., Franco F., Peshock R., Thompson M., and Giroir B. Cardiac failure in transgenic mice with myocardial expression of tumor necrosis factor-α. Circulation 97 (1998) 1375-1381
6. Cain B.S., Meldrum D.R., Meng X., Dinarello C.A., Shames B.O., Banerjee A., and Harken A.H. p38 MAPK inhibition decreases TNF-α production and enhances postischemic human myocardial function. The Journal of Surgical Research 83 (1999) 7-12
7. Calderone A., Oto T., Rosenfeldt F., and Pepe S. Inhibition of p38 MAPK and inflammatory cytokines in donor thoracic organs from a rat model of brain death. Journal of Molecular and Cellular Cardiology 41 (2006) 734-735
8. Joachim S.C., Wuenschig D., Pfeiffer N., and Grus F.H. IgG antibody patterns in aqueous humor of patients with primary open angle glaucoma and pseudoexfoliation glaucoma. Molecular Vision 13 (2007) 1573-1579
9. Kubota T., Miyagishima M., Alvarez R.J., Kormos R., Rosenblum W.D., Demetris A.J., Semigran M.J., Dec G.W., Holubkov R., McTiernan C.F., Mann D.L., Feldman A.M., and McNamara D.M. Expression of proinflammatory cytokines in the failing human heart: comparison of recent-onset and end-stage congestive heart failure. The Journal of Heart and Lung Transplantation 19 (2000) 819-824
10. Lambert E., Dasse E., Haye B., and Petitfrere E. TIMPs as multifacial proteins. Critical Reviews in Oncology/Hematology 49 (2004) 187-198
11. Li M., Georgakopoulos D., Lu G., Hester L., Kass D.A., Hasday J., and Wang Y. p38 MAP kinase mediates inflammatory cytokine induction in cardiomyocytes and extracellular matrix remodeling in heart. Circulation 111 (2005) 2494-2502
12. Li W., Li J., Ashok M., Wu R., Chen D., Yang L., Yang H., Tracey K.J., Wang P., Sama A.E., and Wang H. A cardiovascular drug rescues mice from lethal sepsis by selectively attenuating a late-acting proinflammatory mediator, high mobility group box 1. Journal of Immunology 178 (2007) 3856-3864
13. Liao P., Georgakopoulos D., Kovacs A., Zheng M., Lerner D., Pu H., Saffitz J., Chien K., Xiao R.P., Kass D.A., and Wang Y. The in vivo role of p38 MAP kinases in cardiac remodeling and restrictive cardiomyopathy. Proceedings of the National Academy of Sciences of the United States of America 98 (2001) 12283-12288
14. Long L., Soeken K., and Ernst E. Herbal medicines for the treatment of osteoarthritis: a systematic review. The Journal of Rheumatology 40 (2001) 779-793
15. Lovelock J.D., Baker A.H., Gao F., Dong J.F., Bergeron A.L., McPheat W., Sivasubramanian N., and Mann D.L. Heterogeneous effects of tissue inhibitors of matrix metalloproteinases on cardiac fibroblasts. The American Journal of Physiology 288 (2005) H461-H468
16. Ortiz L.A., Lasky J., Gozal E., Ruiz V., Lungarella G., Cavarra E., Brody A.R., Friedman M., Pardo A., and Selman M. Tumor necrosis factor receptor deficiency alters matrix metalloproteinase 13/tissue inhibitor of metalloproteinase 1 expression in murine silicosis. American Journal of Respiratory and Critical Care Medicine 163 (2001) 244-252
17. Petrich B.G., and Wang Y. Stress-activated MAP kinases in heart failure: new insights from in vivo studies. Trends in Cardiovascular Medicine 14 (2004) 50-55
18. Rohde L.E., Ducharme A., Arroyo L.H., Aikawa M., Sukhova G.H., Lopez-Anaya A., McClure K.F., Mitchell P.G., Libby P., and Lee R.T. Matrix metalloproteinase inhibition attenuates early left ventricular enlargement after experimental myocardial infarction in mice. Circulation 99 (1999) 3063-3070
19. Schiller N.B., Shah P.M., Crawford M., DeMaria A., Devereux R., Feigenbaum H., Gutgesell H., Reichek N., Sahn D., and Schnittger I. Recommendations for quantification of the left ventricle by two-dimensional echocardiography. American Society of Echocardiography Committee on Standards. Subcommittee on quantification of two-dimensional echocardiograms. Journal of the American Society of Echocardiography 2 (1989) 358-367
20. Shao Z.H., Li C.Q., Vanden Hoek T.L., Becker L.B., Schumacker P.T., Wu J.A., Attele A.S., and Yuan C.S. Extract from scutellaria baicalensis georgi attenuates oxidant stress in cardiomyocytes. Journal of Molecular and Cellular Cardiology 31 (1999) 1885-1895
21. Silvestre J.S., Heymes C., Oubenaissa A., Robert V., Aupetit-Faisant B., Carayon A., Swynghedauw B., and Delcayre C. Activation of cardiac aldosterone production in rat myocardial infarction; effect of angiotensin II receptor blockade and role in cardiac fibrosis. Circulation 99 (1999) 2694-2701
22. Sivasubramanian N., Coker M.L., Kurrelmeyer K.M., MacLellan W.R., DeMayo F.J., Spinale F.G., and Mann D.L. Left ventricular remodeling in transgenic mice with cardiac restricted overexpression of tumor necrosis factor. Circulation 104 (2001) 826-831
23. Sun Y., Zhang J.Q., Zhang J., and Lamparter S. Cardiac remodeling by fibrous tissue after infarction in rats. The Journal of Laboratory and Clinical Medicine 135 (2000) 316-323
24. Swynghedauw B. Molecular mechanisms of myocardial remodeling. Physiology Review 79 (1999) 215-262
25. Theiss A.L., Simmons J.G., Jobin C., and Lund P.K. Tumor necrosis factor TNFα increases collagen accumulation and proliferation in intestinal myofibroblasts via TNF receptor 2. Biological Chemistry 280 (2005) 36099-36109
26. Wang M., Baker L., Tsai B.M., Meldrum K.K., and Meldrum D.R. Sex differences in the myocardial inflammatory response to ischemia-reperfusion injury. American Journal of Physiology. Endocrinology and Metabolism 288 (2005) E321-E326
27. Yeom M.J., Lee H.C., Kim G.H., Lee H.J., Shim I., Oh S.K., Kang S.K., and Hahm D.H. Anti-arthritic effects of ephedra sinica STAPF herb-acupuncture: inhibition of lipopolysaccharide-induced inflammation and adjuvant-induced polyarthritis. Journal of Pharmacological Sciences 100 (2006) 41-50
28. Zhang J.D. Clinical study on the effect of shumai capsule in treating angina pectoris. International Congress of Oriental Medicine, vol. 10 (2002), Korean Oriental Medical Society, Chungcheongbuk-do Association of Korean Oriental Medicine, Osong International Bio Exposition Organizing Committee 44
29. Zhang J.D., Gan L.J., Wang S.H., Chen H., and Li L. Clinical study on the effects of shu mai capsule in treating angina pectory. Journal of Shandong University of TCM 25 (2001) 24-26